District Court, D. Delaware November 16, 2016, Civ. No. 14-874-SLR (Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc.)

OPINION

Robinson, District Judge

I. INTRODUCTION

This action arises out of the filing of Abbreviated New Drug Application (“ANDA”) No. 205149 by defendant Teva *785Pharmaceuticals USA, Inc. (“Teva”) seeking to produce and market a generic mometasone furoate nasal spray. (D.I. 123) On July 3, 2014, plaintiff Merck Sharp & Dohme Corp. (“Merck”) brought this action alleging infringement of U.S.